GET THE FULL COMPANY
ANALYSIS BUNDLE FOR
Praxsyn Corp.
Who Owns Praxsyn Corp.?
Understanding Praxsyn Corporation's ownership is key to grasping its market influence and strategic path. The company's current structure was significantly shaped by a merger on March 31, 2014, which also marked its name change.
Originally established as American Antiquities, Inc. on June 5, 2005, in Illinois, Praxsyn Corporation has transformed into a healthcare-focused holding company based in Scottsdale, Arizona. Its operations now center on acquiring and managing healthcare assets to boost financial and operational performance.
Praxsyn Corporation is publicly traded on the OTC Markets under the ticker symbol PXYN, indicating a broad base of public shareholders. The company's strategic direction is influenced by its focus on healthcare solutions, including revenue cycle management, as highlighted in analyses like the Praxsyn Corp. BCG Matrix.
Who Founded Praxsyn Corp.?
The initial ownership of Praxsyn Corp., established as American Antiquities, Inc. on June 5, 2005, in Illinois, was centered around antiques and collectibles. The company's ownership structure underwent a significant transformation through a reverse acquisition.
American Antiquities, Inc. was the original name of the company. Its initial operations focused on the antiques and collectibles market.
A pivotal event occurred on August 13, 2010. This date marked a significant shift in the company's ownership and operational direction.
American Antiquities, Inc. acquired 100% of Pet Airways, Inc.'s stock. This involved an exchange of 25,000,000 shares of common stock.
The acquisition resulted in Pet Airways, Inc.'s controlling stockholders gaining control. These individuals became the primary owners of the combined entity.
The 25,000,000 shares represented approximately 73% of the issued and outstanding capital stock. This solidified the new ownership's majority stake.
While original founders of American Antiquities, Inc. are not widely detailed, the controlling stockholders of Pet Airways, Inc. emerged as the dominant early owners.
The reverse acquisition of Pet Airways, Inc. by American Antiquities, Inc. on August 13, 2010, was a defining moment for Praxsyn Corp. ownership. This transaction effectively transferred control to the controlling stockholders of Pet Airways, Inc., who then became the principal owners of the newly combined entity, which was subsequently renamed Pet Airways, Inc. This event significantly reshaped the Praxsyn Corp ownership structure, moving control away from the original founders of American Antiquities, Inc. to the stakeholders of the acquired airline. Understanding this pivotal acquisition is key to tracing the Praxsyn Corp company history ownership and identifying who owns Praxsyn today. This strategic move also impacted the Competitors Landscape of Praxsyn Corp., as the company pivoted its focus.
How Has Praxsyn Corp.’s Ownership Changed Over Time?
The ownership of Praxsyn Corp. has seen significant shifts, notably following a merger on March 31, 2014, which led to its rebranding as Praxsyn Corporation. Post-merger, the PDC control group, including Mesa Pharmacy, Inc., secured approximately 40% of Praxsyn's common stock on a diluted basis. This group also held Series D preferred shares, giving them about 63% of the company's diluted voting power.
| Entity | Ownership Stake (Post-Merger) | Voting Power (Post-Merger) |
| PDC control group (incl. Mesa Pharmacy, Inc.) | ~40% common stock (diluted) | ~63% diluted voting power |
As a publicly traded entity on the OTC Markets under the ticker PXYN, Praxsyn Corporation's ownership is distributed among various shareholders. While detailed beneficial ownership filings for the past year are not readily accessible via SEC portals as of July 2025, information regarding major institutional investors and their holdings for 2024-2025 would typically be disclosed in the company's SEC filings. Praxsyn's operational structure includes key subsidiaries such as Mesa Pharmacy, Inc., which handles workers' compensation accounts receivable, and Nevada Health RX, Inc., focused on marketing medical supplies. Praxsyn Capital Corporation (PraxCapita) also plays a role by offering revenue cycle management solutions.
The Praxsyn Corp ownership structure reflects a history of strategic consolidation and evolving stakeholder influence. Understanding who owns Praxsyn is key to grasping its strategic direction.
- The PDC control group, including Mesa Pharmacy, Inc., was a significant stakeholder post-2014 merger.
- This group held a substantial portion of voting power due to preferred share ownership.
- Praxsyn Corporation is a publicly traded company, indicating a dispersed shareholder base.
- Key subsidiaries like Mesa Pharmacy, Inc. and Nevada Health RX, Inc. are integral to its operations.
- For detailed insights into Praxsyn Corp. investor relations and its board of directors, SEC filings are the primary source.
Who Sits on Praxsyn Corp.’s Board?
As of July 12, 2023, Praxsyn Corp's board structure simplified significantly with Sean Daly assuming the role of CEO and serving as the sole board member. This followed the departure of Daniel Oswald from all company positions.
| Date | Board Member | Role |
|---|---|---|
| July 12, 2023 | Sean Daly | CEO, Board Member |
| Prior to July 12, 2023 | Daniel Oswald | Interim CEO, Board Member |
| February 2021 | Frank Brady | Former CEO |
| September 14, 2018 | Dr. Sanjeev Kaila | Board Member |
| September 14, 2018 | Daniel A. Barretto | Board Member |
| September 14, 2018 | Thomas J. Patire | Board Member |
The voting power within Praxsyn Corp has historically been concentrated, particularly following a 2014 merger. The PDC control group, through its Series D preferred shares, commanded approximately 63% of the company's diluted voting power. This arrangement highlights a substantial degree of influence held by these preferred shareholders over corporate decisions. While specific details regarding recent voting dynamics or activist investor involvement for 2024-2025 are not readily available, past events, such as the SEC settlement involving former CEO Frank Brady, have demonstrably shaped leadership and, by extension, the composition of the board, impacting the overall Praxsyn Corp ownership landscape.
The concentration of voting power is a critical factor in understanding Praxsyn Corp ownership. Past structures indicate significant control by specific shareholder groups.
- Series D preferred shares held by the PDC control group controlled approximately 63% of diluted voting power after the 2014 merger.
- This level of control suggests a strong influence on corporate governance and strategic direction.
- Changes in leadership, such as the CEO transition in July 2023, can reflect underlying shifts in ownership influence.
- Understanding these historical voting patterns is key to analyzing the current Praxsyn Corp ownership structure.
- For a deeper dive into how strategic decisions are made, explore the Marketing Strategy of Praxsyn Corp.
What Recent Changes Have Shaped Praxsyn Corp.’s Ownership Landscape?
Praxsyn Corp has navigated a period of significant leadership shifts and ongoing efforts to resolve financial and operational challenges over the past few years. These changes reflect a strategic push towards stabilization and future growth.
| Event | Date | Key Personnel |
|---|---|---|
| CEO Resignation | February 2021 | Frank Brady |
| Interim CEO Appointment | February 2021 | Daniel Oswald |
| CEO Resignation | July 12, 2023 | Daniel Oswald |
| CEO and Board Appointment | July 12, 2023 | Sean Daly |
The company is actively engaged in completing its outstanding financial filings to regain current status, alongside exploring various financing avenues, business development initiatives, and restructuring opportunities. A notable effort involves pursuing unclaimed property for its subsidiary, Mesa Pharmacy, Inc., with potential to recover up to $30,000. These actions are integral to the company's broader strategy to fortify its operational base and improve its financial health. While specific details on share buybacks, secondary offerings, or major mergers and acquisitions for 2024-2025 are not publicly detailed, the company's focus on enhancing operational efficiency and revenue cycle management signals its commitment to sustainable growth.
Sean Daly assumed the role of CEO on July 12, 2023, becoming the sole board member. This followed Daniel Oswald's resignation from the interim CEO position.
Praxsyn Corp is focused on completing missing filings and exploring financing and restructuring opportunities. The company is also working to recover unclaimed property for Mesa Pharmacy, Inc.
The company's current strategic direction emphasizes operational improvements and revenue cycle management. These efforts are aimed at bolstering the business for future stability and growth.
Recent developments indicate a consolidation of leadership under Sean Daly. Understanding the Target Market of Praxsyn Corp. can provide further context on its business strategy and potential ownership trends.
- What is Brief History of Praxsyn Corp. Company?
- What is Competitive Landscape of Praxsyn Corp. Company?
- What is Growth Strategy and Future Prospects of Praxsyn Corp. Company?
- How Does Praxsyn Corp. Company Work?
- What is Sales and Marketing Strategy of Praxsyn Corp. Company?
- What are Mission Vision & Core Values of Praxsyn Corp. Company?
- What is Customer Demographics and Target Market of Praxsyn Corp. Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.